CELEX:62025TO0637:           Order of the President of the General Court of 12 December 2025.#Merck Europe BV v European Commission.#Interim relief – Medicinal products for human use – Marketing authorisation for MAVENCLAD – cladribine – Request for administrative assistance concerning the scope and extent of the marketing authorisation – Application for suspension of operation of a measure – No urgency.#Case T-637/25 R.

EUR LEX - RSS
Ta dokument v slovenščini ne obstaja.

CELEX:62025TO0637:           Order of the President of the General Court of 12 December 2025.#Merck Europe BV v European Commission.#Interim relief – Medicinal products for human use – Marketing authorisation for MAVENCLAD – cladribine – Request for administrative assistance concerning the scope and extent of the marketing authorisation – Application for suspension of operation of a measure – No urgency.#Case T-637/25 R.

EUR LEX - RSS
Ta dokument v slovenščini ne obstaja.

CELEX:62025TO0637:           Order of the President of the General Court of 12 December 2025.#Merck Europe BV v European Commission.#Interim relief – Medicinal products for human use – Marketing authorisation for MAVENCLAD – cladribine – Request for administrative assistance concerning the scope and extent of the marketing authorisation – Application for suspension of operation of a measure – No urgency.#Case T-637/25 R.

EUR LEX - RSS
Ta dokument v slovenščini ne obstaja.

CELEX:62025TO0637:           Order of the President of the General Court of 12 December 2025.#Merck Europe BV v European Commission.#Interim relief – Medicinal products for human use – Marketing authorisation for MAVENCLAD – cladribine – Request for administrative assistance concerning the scope and extent of the marketing authorisation – Application for suspension of operation of a measure – No urgency.#Case T-637/25 R.

EUR LEX - RSS
Ta dokument v slovenščini ne obstaja.

CELEX:62025TO0637:           Order of the President of the General Court of 12 December 2025.#Merck Europe BV v European Commission.#Interim relief – Medicinal products for human use – Marketing authorisation for MAVENCLAD – cladribine – Request for administrative assistance concerning the scope and extent of the marketing authorisation – Application for suspension of operation of a measure – No urgency.#Case T-637/25 R.

EUR LEX - RSS
Ta dokument v slovenščini ne obstaja.

CELEX:62021TO0133:           Ordonnance du Tribunal (huitième chambre) du 11 décembre 2025.#Jegors Buimisters, en qualité d’héritier de Igors Buimisters et Aleksandra Buimistere, en qualité d’héritière de Igors Buimisters contre Banque centrale européenne.#Recours en indemnité – Politique économique et monétaire – Surveillance prudentielle des établissements de crédit – Missions spécifiques de surveillance confiées à la BCE – Décision de retrait de l’agrément d’un établissement de crédit – Violation suffisamment caractérisée d’une règle de droit conférant des droits aux particuliers – Recours manifestement dépourvu de tout fondement en droit.#Affaire T-133/21.

EUR LEX - RSS
Ta dokument v slovenščini ne obstaja.

CELEX:62025TO0254:           Order of the General Court (Sixth Chamber) of 11 December 2025.#Skechers USA, Inc. II v European Union Intellectual Property Office.#EU trade mark – International registration designating the European Union – Word mark HANDS FREE SLIP-INS – Absolute grounds for refusal – Descriptive character – No distinctive character – Article 7(1)(b) and (c) of Regulation (EU) 2017/1001 – Obligation to state reasons – Article 94(1) of Regulation 2017/1001 – Action manifestly lacking any foundation in law.#Case T-254/25.

EUR LEX - RSS
Ta dokument v slovenščini ne obstaja.